APVO Aptevo: Forvard P/S multiplikatori
GURU.Markets ma'lumotlari ushbu grafikda aks ettirilgan forward P/S dinamikasi joriy ko'rsatkich 2.90 ga teng ekanligini ko'rsatmoqda. ADAPTIR patent portfeli FDA ning qat'iy nazoratiga qaramay, biotexnologiya sohasidagi raqobatni cheklaydi. Aptevo Therapeutics (APVO) o'smalarga qarshi kurashish uchun maqsadli immunoterapiyani ishlab chiqishga e'tibor qaratadi. Ekotizim bemorlarni sinovlarda saqlab qoladi, ishlab chiqish jarayoni esa sog'liqni saqlash gigantlari bilan hamkorlik orqali moliyalashtiriladi.
APVO (aptevotherapeutics.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Aptevo Therapeutics|APVO - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Aptevo Therapeutics Inc.|APVO - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Aptevo Therapeutics Inc.|APVO - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Aptevo Therapeutics|Tezkor likvidlik ko‘rsatkichi aptevotherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
APVO - Soliqlar to‘langandan keyingi foyda|Prognoz qilingan kelajakdagi foyda Aptevo Therapeutics|APVO - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Aptevo Therapeutics Inc.|APVO - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Aptevo Therapeutics Inc.|APVO - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Aptevo Therapeutics|APVO - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi aptevotherapeutics.com|APVO - Joriy yilda bir aksiya uchun foyda dinamikasi|Keyingi yil uchun foyda o'sishi prognozi Aptevo Therapeutics
- sotuv hajmi va tushum haqida ma'lumot:
Kompaniyaning jamlanma tahliliyoti:APVO (Aptevo)
Muvaffaqiyati antitelolarni test qilish natijalariga bog'liq bo'lgan Aptevo Therapeutics (APVO) biotexnologiya startapi uchun oldingi P/S koeffitsiyenti kutilayotgan daromadlar asosida aktivning bozor qiymatini belgilaydi. Biznesning haddan tashqari qimmat baholanganini o'z vaqtida aniqlash yoki fundamental zaiflik xavfi minimal bo'lgan kirish nuqtasini topish uchun investorlarning prognoz qilingan P/S qiymatini kapital jalb qilish stavkalari va rivojlanish bosqichlari bilan solishtirishi juda muhimdir.
Raqobatchilar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati IMVT (immunovant.com)|Forvard narx/daromad multiplikatori KNSA|GRFS (Grifols SA) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori ADPT|CLDX - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Aurinia Pharmaceuticals - Forvard narx/daromad multiplikatori|biocryst.com - Narxning prognoz qilingan daromadga nisbati|VERA - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Forvard narx/daromad multiplikatori|AbCellera Corp - Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori TRML|PGEN (precigen.com) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori PHAR|NKTR (Nektar Therapeutics Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori UPB (Upstream Bio Corp)|Zenas Corp (ZBIO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx GOSS (gossamerbio.com)|KALV: Forvard P/S multiplikatori|Septerna, Inc. (SEPN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals Inc|Savara Pharma - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori RIGL|ANAB - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Astria Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori enGene Holdings Inc ENGN|RAPT: Forvard narx/daromad multiplikatori|Aerovate Therapeutics Inc - Narxning kutilayotgan daromadga nisbati|ACRS: Forvard P/S multiplikatori|KYTX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|TLSA (Tiziana Life Sciences Ltd) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cabaletta Bio Inc. (CABA)|Narxning prognoz qilingan daromadga nisbati Ventyx Bio (VTYX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Theratechnologies, Inc|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|Forvard P/S multiplikatori eledon.com ELDN|AGEN - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CLYM|ZURA (Zura Bio Limited) - Forvard narx/daromad multiplikatori|ATYR (aTyr Pharmaceuticals) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ikena Oncology, Inc. IMA|Narxning prognoz qilingan daromadga nisbati Shattuck Labs, Inc. (STTK)|EQ: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Sotuvga nisbatan forvard narx IMUX|Atara Biotherapeutics Inc - Forvard P/S multiplikatori|IFRX - Forvard P/S multiplikatori|X4 Pharmaceuticals, Inc. (XFOR) - Narxning prognoz qilingan daromadga nisbati|Adicet Bio, Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Celularity Inc|Forvard narx/daromad multiplikatori INmune Bio Corporation (INMB)|Forvard P/S multiplikatori BRNS|Forvard P/S multiplikatori kezarlifesciences.com (KZR)|SAB Biotherapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AKTX|Enlivex Therapeutics, Ltd. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Q32 Bio Inc. QTTB|GeoVax Labs, Inc. (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori edesabiotech.com|Narxning prognoz qilingan daromadga nisbati iBio|Forvard narx/daromad multiplikatori Carisma Tx (CARM)|Forvard narx/daromad multiplikatori XTLB (XTL Biopharmaceuticals, Ltd.)|Forvard P/S multiplikatori boltbio.com (BOLT)|Narxning prognoz qilingan daromadga nisbati HCW Biologics HCWB|AIM: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Aditxt Corp - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati GRI Bio Inc|XRTX: Forvard P/S multiplikatori|Vyome Therapeutics (HIND) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Revelation Biosciences|indaptusrx.com - Kelajakdagi narxning daromadga nisbati|Forvard narx/daromad multiplikatori SCNI (Scinai Immunotherapeutics Ltd.)|Narxning kutilayotgan daromadga nisbati CALI|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Allakos Inc (ALLK) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|HOOK: Forvard narx/daromad multiplikatori|IGMS: Narxning prognoz qilingan daromadga nisbati|iTeos Therapeutics, Inc. (ITOS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ocean Biomedical Inc (OCEA)|Forvard narx/daromad multiplikatori TCBP|THRD: Sotuvga nisbatan forvard narx
